Literature DB >> 23114619

A poor imitation of a natural process: a call to reconsider the iPSC engineering technique.

Yemin Zhang1, Lin Yao, Xiya Yu, Jun Ou, Ning Hui, Shanrong Liu.   

Abstract

Reprogramming somatic cells into a pluripotent state is expected to initiate a new era in medicine. Because the precise underlying mechanism of reprogramming remains unclear, many efforts have been made to optimize induced pluripotent stem cell (iPSC) engineering. However, satisfactory results have not yet been attained. In this review, we focus on recent roadblocks in iPSC reprogramming engineering, such as the inefficiency of the process, tumorigenicity and heterogeneity of the generation. We conclude that cell reprogramming is a naturally occurring phenomenon rather than a biological technique. We will only be able to mimic the natural process of reprogramming when we fully understand its underlying mechanism. Finally, we highlight the alternative method of direct conversion, which avoids the use of iPSCs to generate cell materials for patient-specific cell therapy.

Entities:  

Mesh:

Year:  2012        PMID: 23114619      PMCID: PMC3562298          DOI: 10.4161/cc.22575

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  101 in total

1.  Generation of induced pluripotent stem cells from human adipose-derived stem cells without c-MYC.

Authors:  Tetsuhiro Aoki; Hiroe Ohnishi; Yasuaki Oda; Mika Tadokoro; Mari Sasao; Hiroyuki Kato; Koji Hattori; Hajime Ohgushi
Journal:  Tissue Eng Part A       Date:  2010-07       Impact factor: 3.845

2.  Suppression of induced pluripotent stem cell generation by the p53-p21 pathway.

Authors:  Hyenjong Hong; Kazutoshi Takahashi; Tomoko Ichisaka; Takashi Aoi; Osami Kanagawa; Masato Nakagawa; Keisuke Okita; Shinya Yamanaka
Journal:  Nature       Date:  2009-08-09       Impact factor: 49.962

3.  Oct4 and klf4 reprogram dermal papilla cells into induced pluripotent stem cells.

Authors:  Su-Yi Tsai; Carlos Clavel; Soo Kim; Yen-Sin Ang; Laura Grisanti; Dung-Fang Lee; Kevin Kelley; Michael Rendl
Journal:  Stem Cells       Date:  2010-02       Impact factor: 6.277

4.  Induced pluripotent stem cells generated without viral integration.

Authors:  Matthias Stadtfeld; Masaki Nagaya; Jochen Utikal; Gordon Weir; Konrad Hochedlinger
Journal:  Science       Date:  2008-09-25       Impact factor: 47.728

5.  Reprogramming of human somatic cells to pluripotency with defined factors.

Authors:  In-Hyun Park; Rui Zhao; Jason A West; Akiko Yabuuchi; Hongguang Huo; Tan A Ince; Paul H Lerou; M William Lensch; George Q Daley
Journal:  Nature       Date:  2007-12-23       Impact factor: 49.962

6.  A high-efficiency system for the generation and study of human induced pluripotent stem cells.

Authors:  Nimet Maherali; Tim Ahfeldt; Alessandra Rigamonti; Jochen Utikal; Chad Cowan; Konrad Hochedlinger
Journal:  Cell Stem Cell       Date:  2008-09-11       Impact factor: 24.633

7.  Pluripotency can be rapidly and efficiently induced in human amniotic fluid-derived cells.

Authors:  Chunliang Li; Junmei Zhou; Guilai Shi; Yu Ma; Ying Yang; Junjie Gu; Hongyao Yu; Shibo Jin; Zhe Wei; Fang Chen; Ying Jin
Journal:  Hum Mol Genet       Date:  2009-08-13       Impact factor: 6.150

8.  Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts.

Authors:  Masato Nakagawa; Michiyo Koyanagi; Koji Tanabe; Kazutoshi Takahashi; Tomoko Ichisaka; Takashi Aoi; Keisuke Okita; Yuji Mochiduki; Nanako Takizawa; Shinya Yamanaka
Journal:  Nat Biotechnol       Date:  2007-11-30       Impact factor: 54.908

9.  Direct cell reprogramming is a stochastic process amenable to acceleration.

Authors:  Jacob Hanna; Krishanu Saha; Bernardo Pando; Jeroen van Zon; Christopher J Lengner; Menno P Creyghton; Alexander van Oudenaarden; Rudolf Jaenisch
Journal:  Nature       Date:  2009-11-08       Impact factor: 49.962

10.  In vivo reprogramming of adult pancreatic exocrine cells to beta-cells.

Authors:  Qiao Zhou; Juliana Brown; Andrew Kanarek; Jayaraj Rajagopal; Douglas A Melton
Journal:  Nature       Date:  2008-08-27       Impact factor: 49.962

View more
  7 in total

Review 1.  Preclinical studies for induced pluripotent stem cell-based therapeutics.

Authors:  John Harding; Oleg Mirochnitchenko
Journal:  J Biol Chem       Date:  2013-12-20       Impact factor: 5.157

Review 2.  Bacterial-induced cell reprogramming to stem cell-like cells: new premise in host-pathogen interactions.

Authors:  Samuel Hess; Anura Rambukkana
Journal:  Curr Opin Microbiol       Date:  2014-12-23       Impact factor: 7.934

Review 3.  Engineering Islets From Stem Cells: The Optimal Solution for the Treatment of Diabetes?

Authors:  Suya Du; Yanjiao Li; Zhen Geng; Qi Zhang; Leo H Buhler; Carmen Gonelle-Gispert; Yi Wang
Journal:  Front Immunol       Date:  2022-04-27       Impact factor: 8.786

Review 4.  The mitochondrial H(+)-ATP synthase and the lipogenic switch: new core components of metabolic reprogramming in induced pluripotent stem (iPS) cells.

Authors:  Alejandro Vazquez-Martin; Bruna Corominas-Faja; Sílvia Cufi; Luciano Vellon; Cristina Oliveras-Ferraros; Octavio J Menendez; Jorge Joven; Ruth Lupu; Javier A Menendez
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

5.  Direct reprogramming of mouse fibroblasts to cardiomyocyte-like cells using Yamanaka factors on engineered poly(ethylene glycol) (PEG) hydrogels.

Authors:  Amanda W Smith; Jake D Hoyne; Peter K Nguyen; Dylan A McCreedy; Haytham Aly; Igor R Efimov; Stacey Rentschler; Donald L Elbert
Journal:  Biomaterials       Date:  2013-06-14       Impact factor: 12.479

6.  Transcriptome Profiling of Patient-Specific Human iPSC-Cardiomyocytes Predicts Individual Drug Safety and Efficacy Responses In Vitro.

Authors:  Elena Matsa; Paul W Burridge; Kun-Hsing Yu; John H Ahrens; Vittavat Termglinchan; Haodi Wu; Chun Liu; Praveen Shukla; Nazish Sayed; Jared M Churko; Ningyi Shao; Nicole A Woo; Alexander S Chao; Joseph D Gold; Ioannis Karakikes; Michael P Snyder; Joseph C Wu
Journal:  Cell Stem Cell       Date:  2016-08-18       Impact factor: 24.633

7.  Current issues in medically assisted reproduction and genetics in Europe: research, clinical practice, ethics, legal issues and policy. European Society of Human Genetics and European Society of Human Reproduction and Embryology.

Authors:  Joyce C Harper; Joep Geraedts; Pascal Borry; Martina C Cornel; Wybo Dondorp; Luca Gianaroli; Gary Harton; Tanya Milachich; Helena Kääriäinen; Inge Liebaers; Michael Morris; Jorge Sequeiros; Karen Sermon; Françoise Shenfield; Heather Skirton; Sirpa Soini; Claudia Spits; Anna Veiga; Joris Robert Vermeesch; Stéphane Viville; Guido de Wert; Milan Macek
Journal:  Eur J Hum Genet       Date:  2013-11       Impact factor: 4.246

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.